Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Dofetilide restores sinus rhythm without increasing risk of death in patients with CHF

Sep. 21, 1999

New isomer of toremifene metabolite has favorable antiestrogenic and hypolipidemic effects

Sep. 21, 1999

Chimeric anti-factor D MAb from Tanox for complement-mediated disorders

Sep. 21, 1999

Ischemia-selective mechanism implicated in the antiarrhythmic activity of PAF antagonist

Sep. 20, 1999

AstraZeneca seeks FDA approval of Toprol-XL as heart failure treatment

Sep. 17, 1999

K(ATP) channel opener with improved cardioprotective efficacy designed at BMS

Sep. 16, 1999

BASF's new ET antagonists described in patent literature

Sep. 16, 1999

Cypros receives additional notice of allowance concerning U.S. patent on Cordox

Sep. 16, 1999

Modulators of cGMP production in development at HMR

Sep. 15, 1999

BiDil combination therapy offers benefits for black CHF patients

Sep. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...